PEOPLE ON THE MOVE
PPD-SNBL
CRO PPD (Pharmaceutical Product Development) has appointed Yasumasa Kurioka to lead its JV with Shin Nippon Biomedical Laboratories Ltd.
The joint venture, named PPD-SNBL, was formed earlier this year to expand clinical development services in Japan.
Kurioka most recently served as the head of clinical operations in Japanfor Parexel. During the 20 years prior to that, he held a variety of clinical research, project management and operations leadership roles with Eli Lilly and the former Ciba-Geigy in Japan.
“Yasu brings extensive clinical operations leadership experience, as well as significant scientific expertise to his position,” said Paul Colvin, CEO of PPD-SNBL. “I am confident he will implement innovative operational strategies that will enable PPD-SNBL to use its extensive resources, long-term experience and local expertise to further meet its clients’ needs in this important global market.”